Antimicrobial Resistance: The Pandemic in the Shadows
COVID-19 demonstrated the power of infectious diseases to reset our lives. There is another grave and growing danger to human health: antimicrobial resistance (AMR). Ever since their discovery, antibiotics have dramatically changed the management and treatment of infections in humans and animals. Paradoxically, their use and selective pressure leads to genetic changes in bacteria critical for their survival, and gives rise to antimicrobial resistance (AMR). This talk by Jyoti Joshi delineated how AMR has reached pandemic proportions, and showed that unless tackled urgently, the antibiotics used today will be unavailable to future generations.
About the Physician
Jyoti Joshi MBBS MD (Community Medicine) & MSc (Infectious diseases) is Head - South Asia at the Center for Disease Dynamics, Economics & Policy (CDDEP) and an Adjunct Professor at Amity Institute of Public Health, Amity University, Uttar Pradesh, India. A medical doctor with specialization in Community Medicine and Infectious diseases, Dr. Jyoti has worked in public health programs for two decades. Her research interests include antimicrobial resistance (AMR), vaccines, infectious diseases, and health systems. As part of the Global Antibiotic Research Partnership (GARP) project at CDDEP, she supported country working groups in 6 Asian countries to develop projects to address AMR.
